University of Maryland Greenebaum Comprehensive Cancer Center. NCI-designated comprehensive cancer center. National leader in cancer care and research.
Baltimore, Maryland
Joined December 2008
- Tweets1.9K
- Following646
- Followers8.2K
- Likes343
Why does cancer research matter? Ask Dr. Andrea Levine, who was diagnosed with brain cancer while six months pregnant and walked in this year's Maryland Half Marathon & 5K to support the cause. Her story, via @wbaltv11: wbaltv.com/article/doctor-ca…
“I mean, it’s a whole new life.” Jessica Ceja talks about receiving breakthrough gene therapy for sickle cell disease in this @NBCWashington report. nbcwashington.com/news/healt…
Gene therapy may dramatically change the lives of patients with sickle cell disease. See how UMGCCC is transforming care in the @BaltimoreBanner story featuring UMGCCC & @UMmedschool’s Dr.'s Jean Yared Jennie Law, & their 41-year-old patient Jessica Ceja. thebanner.com/community/publ…
Monday at 7 p.m., tune in to @marylandpubtv's Your Health. UMMC gastroenterologist Dr. Ekta Gupta discusses the rise in colorectal cancer among younger adults, what may be driving it, and steps people can take to help reduce their cancer risk.
To watch a livestream of Monday’s program, visit: mpt.org/programs/direct-conn…
UMGCCC retweeted
Ready for the #StomachCancer Patient Empowerment Summit hosted by @StoCANcer. Looking forward to a great day! #Gastric #CancerResearch
@UMGCCC
UMGCCC retweeted
WATCH 👀: Ranee Mehra, MD, of @UMGCCC discusses efficacy data for subcutaneous amivantamab plus pembrolizumab in HNSCC from multiple clinical trials.
See the whole video here ➡️: hubs.li/Q045Y7-J0
#hncsm #oncology
UMGCCC retweeted
Great way to close out #SSO2026 with 2 amazing presentations by Dr Rachael Belcher and @AmberFGallanis on #CDH1 research. @MarylandSurg @UMGCCC
Rates of colorectal cancer are rising in young people. Hear more from Dr. Ekta Gupta, Chief of Gastroenterology at UMMC's Midtown Campus and Associate Professor of Medicine @UMmedschool, in @wbaltv11's story about risk factors and symptoms to look out for.
wbaltv.com/article/colorecta…
UMGCCC retweeted
Proud of our speakers at #ACRO2026 & #ACROSEAL 2026, expanding our department’s missions in sharing cutting-edge #radonc research and leadership skills! #RadiatingExcellence Dr. Jason Molitoris @JKMolitoris, Dr. Zak Rana @ZakieRana, Jamie LePage, Kimberly Simmons-Lee & Melissa Albright
UMGCCC retweeted
The PrE0510 #ClinicalTrial, led by @teekayowo of @UMGCCC, aims to determine the optimal dose of ivonescimab in combo with carboplatin & etoposide for patients with #SmallCellLungCancer. More: bit.ly/PrE0510 #LCSM #LungCancer #SCLC
UMGCCC's Dr. Mark V. Mishra (@MarkMishraMD) is senior author of a recently published study that found a sizeable proportion of patients who experience neurocognitive function failure following brain radiation eventually attain full and sustained cognitive recovery.
Read the full Journal of the National Cancer Institute publication: pubmed.ncbi.nlm.nih.gov/4112…
#CancerResearch
UMGCCC retweeted
Dr Yinin Hu - expert in Thyroid Cancer @UMGCCC and alumnus of @MSKCancerCenter is presenting on genomic testing in DTC. #SSO2026 @MarylandSurgery
UMGCCC retweeted
Proud to support the Maryland Half Marathon & 5K on June 6 and the fight against cancer at @UMGCCC. Together, we make an impact. #MarylandHalfMarathon #5K #ThisIsWhyWeRun secure.ummsfoundation.org/si…
UMGCCC retweeted
WATCH: @RaneeMehra, of @UMGCCC, discusses the design of the OrigAMI-5 trial of pembrolizumab plus amivantamab and carboplatin for recurrent or metastatic HNSCC. #hncsm #oncology
onclive.com/view/dr-mehra-on…
UMGCCC retweeted
📹Watch @RaneeMehra, of @UMGCCC, highlight the future of the HNSCC treatment paradigm! See our site for more head and neck cancer insights from Dr Mehra. #hncsm #oncology
onclive.com/video-series/dr-…
UMGCCC retweeted
WATCH: @RaneeMehra, of @UMGCCC, highlights how the ongoing OrigAMI-5 study may address an unmet need for patients with treatment-naive, recurrent or metastatic HNSCC. #hncsm #oncology
onclive.com/view/dr-mehra-on…
UMGCCC retweeted
The PrE0510 #ClinicalTrial, led by @teekayowo of @UMGCCC, aims to determine the optimal dose of ivonescimab in combo with carboplatin & etoposide for patients with #SmallCellLungCancer. More: clinicaltrials.gov/study/NCT… #LCSM #LungCancer #SCLC
UMGCCC retweeted
WATCH: @RaneeMehra, of @UMGCCC, discusses the toxicities associated with subcutaneous amivantamab in recurrent or metastatic HNSCC. #hncsm #Oncology onclive.com/view/dr-mehra-on…
